There has been increasing evidence for different rates of natural aging in humans and one of the best organs to study human aging is skin. Studies have demonstrated anti-aging effects of topical agents (such as creams, gels, lotions, or ointments) and one of them, retinol or vitamin A, was shown to decrease fine wrinkling in skin of older individuals. Additionally, studies of retinol in humans have largely occurred in white populations and so this study aims to focus on skin aging in individuals of East Asian descent as they represent a majority of the world population. This study aims to better characterize the molecular basis of rejuvenation effects and to potentially discover new topical agents with similar and/or more effective preservation of skin youthfulness.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
110
Retinol in the form of vitamin A lotion
Placebo of Retinol
Stanford Dermatology
Redwood City, California, United States
Number of Genes Upregulated or Downregulated as Assessed by RNA Sequencing (Older Group, Retinol Versus Placebo)
Differences in transcript levels are reported as the number that were upregulated or downregulated in the participant's retinol-treated arm versus their placebo-treated arm.
Time frame: Week 12
Number of Genes Upregulated or Downregulated as Assessed by RNA Sequencing (Younger Group Versus Older Group as Baseline)
Differences in transcript levels are reported as the number of genes that were upregulated or downregulated in the Younger Group participant tissue samples, as compared to a baseline provided by tissue samples collected from the Older Group (prior to their treatment).
Time frame: Week 1
Transepidermal Water Loss
Transepidermal Water Loss of arm skin was measured in units of grams/hours/meters squared.
Time frame: Baseline; Week 12
Severity of Arm Skin Wrinkling
Wrinkling was assessed by the investigator using a 10-point Likert scale (range 0 to 9, lower scores correspond to less wrinkling).
Time frame: Baseline; Week 12
Elasticity on Arm Skin
Elasticity was assessed using cutometry (R2 curve) as millimeters per second
Time frame: Baseline; week 12
Count of Participants With Skin and Subcutaneous Adverse Events as a Measure of Type and Severity of Adverse Events
Skin and subcutaneous adverse events were assessed for this outcome and documented and scored according to CTCAE version 4.03.
Time frame: Baseline through week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.